Corrigendum: Safety of Semaglutide

Código QR

Corrigendum: Safety of Semaglutide

Guardado en:

Detalles Bibliográficos
Autores principales:	Mark M. Smits, Daniël H. Van Raalte
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	glucagon-like peptide-1 receptor agonist (GLP-1RA) oral subcutaneous semaglutide type 2 diabetes safety Diseases of the endocrine glands. Clinical endocrinology RC648-665
Acceso en línea:	https://doaj.org/article/1d6095bb78274de5a98922ae3f3ed6df
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Safety of Semaglutide
por: Mark M. Smits, et al.
Publicado: (2021)

Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date
por: Pearson S, et al.
Publicado: (2019)

Efficacy and safety of dulaglutide in patients with absolute insulin deficiency
por: Kutoh Eiji, et al.
Publicado: (2019)

Unexpected bleeding after Exenatide treatment: a causative relationship or a coincidence?
por: Khoury Johad, et al.
Publicado: (2018)

Associations of Plasma Glucagon Levels with Estimated Glomerular Filtration Rate, Albuminuria and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
por: Hua-Xing Huang, et al.
Publicado: (2021)

Time and metabolic state-dependent effects of GLP-1R agonists on NPY/AgRP and POMC neuronal activity in vivo
por: Yanbin Dong, et al.
Publicado: (2021)

Corrigendum to “Residual β-Cell Function in Type 1 Diabetes Followed for 2 Years after 3C Study”
por: Kun Lin, et al.
Publicado: (2021)

Clinical potential of liraglutide in cardiovascular risk reduction in patients with type 2 diabetes: evidence to date
por: Howell R, et al.
Publicado: (2019)

Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data
por: Kugler AJ, et al.
Publicado: (2018)

A Rare Case of Subcutaneous Insulin Resistance Presumed to be due to Paraneoplastic Process in Pancreatic Adenocarcinoma
por: Kacey Chae, MD, et al.
Publicado: (2021)

Comparative effectiveness of glycemic control in patients with type 2 diabetes treated with GLP-1 receptor agonists: a network meta-analysis of placebo-controlled and active-comparator trials
por: Orme ME, et al.
Publicado: (2017)

Oral semaglutide: the innovation in type 2 diabetes management
por: M. V. Shestakova, et al.
Publicado: (2021)

Advances in Subcutaneous Delivery Systems of Biomacromolecular Agents for Diabetes Treatment
por: Li C, et al.
Publicado: (2021)

Human serum metabolomic analysis reveals progression for high blood pressure in type 2 diabetes mellitus
por: Li Li, et al.
Publicado: (2021)

Quality gaps in screening and monitoring for postoperative hyperglycemia in a Canadian hospital: a retrospective cohort study
por: Anna Cameron, et al.
Publicado: (2021)

The effect of radioiodine treatment on the characteristics of TRAb in Graves’ disease
por: Ya Fang, et al.
Publicado: (2021)

Experimentally induced anti-myeloperoxidase vasculitis is not attenuated in factor B or VISTA deficient mice
por: Fernanda Flórez-Barrós, et al.
Publicado: (2021)

KM55 in the evaluation of IgA containing glomerular diseases
por: Rahul Raj, et al.
Publicado: (2021)

Anti-phospholipase A2 receptor in Non-lupus Patients with Membranous Nephropathy and Crescents
por: Yiqin Zuo, et al.
Publicado: (2021)

Application and Clinical Effectiveness of Antibiotic-Loaded Bone Cement to Promote Soft Tissue Granulation in the Treatment of Neuropathic Diabetic Foot Ulcers Complicated by Osteomyelitis: A Randomized Controlled Trial
por: Regis Ernest Mendame Ehya, et al.
Publicado: (2021)

RET Proto-Oncogene Mutational Analysis in 45 Iranian Patients Affected with Medullary Thyroid Carcinoma: Report of a New Variant
por: Elia Damavandi, et al.
Publicado: (2021)

The Multiple Roles of B Lymphocytes in the Onset and Treatment of Type 1 Diabetes: Interactions between B Lymphocytes and T Cells
por: Yangfan Xiao, et al.
Publicado: (2021)

Association between Markers of Fibrosis and Heart Failure Incidence in Patients with Type 2 Diabetes Mellitus
por: Denis A. Lebedev, et al.
Publicado: (2021)

The Impact of New-Onset Diabetes Mellitus and Hypertension on All-Cause Mortality in an Apparently Healthy Population: A Ten-Year Follow-Up Study
por: Suranut Charoensri, et al.
Publicado: (2021)

Elevated Anthropometric and Metabolic Indicators among Young Adult Offspring of Mothers with Pregestational Diabetes: Early Results from the Transgenerational Effect on Adult Morbidity Study (the TEAM Study)
por: Katherine Bowers, et al.
Publicado: (2021)

HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: the OPTIMAL observational multicenter study
por: Timothy J McDonald, et al.
Publicado: (2021)

GABA induces a hormonal counter-regulatory response in subjects with long-standing type 1 diabetes
por: Daniel Espes, et al.
Publicado: (2021)

Plasma protein N-glycosylation is associated with cardiovascular disease, nephropathy, and retinopathy in type 2 diabetes
por: Femke Rutters, et al.
Publicado: (2021)

Longitudinal associations between family conflict, parent engagement, and metabolic control in children with recent-onset type 1 diabetes
por: Susana R Patton, et al.
Publicado: (2021)

Use of metformin following a population-level intervention to encourage people with pre-diabetes to enroll in the National Diabetes Prevention Program
por: William H Herman, et al.
Publicado: (2021)

Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
por: Peter Rossing, et al.
Publicado: (2021)

Social determinants of health impacting adherence to diabetic retinopathy examinations
por: Cindy X Cai, et al.
Publicado: (2021)

In memoriam: Christian Sauter
por: Hans Ruh, et al.
Publicado: (2021)

Trends in inpatient admissions and emergency department visits for heart failure in adults with versus without diabetes in the USA, 2006–2017
por: K M Venkat Narayan, et al.
Publicado: (2021)

Feasibility and acceptance of a virtual multidisciplinary care programme for patients with type 2 diabetes during the COVID-19 pandemic
por: Sergio Hernández-Jiménez, et al.
Publicado: (2021)

Optimizing treatment goals for long-term health outcomes among patients with type 2 diabetes mellitus
por: Lizheng Shi, et al.
Publicado: (2021)

Frequency of Parathyroid Hormone Assessment in the Evaluation of Hypercalcemia. A Comparison Between Patients With and Without a History of Malignancy in a 20-year Dataset of 20,954 Patients
por: Michael T Sheehan, et al.
Publicado: (2021)

Decreased serum C1Q/TNF-related protein 4 concentrations are associated with type 2 diabetes mellitus
por: Zheng Liu, et al.
Publicado: (2021)

Clinical and molecular characterization of thyroid cancer when seen as a second malignant neoplasm
por: Kristen Romanelli, et al.
Publicado: (2021)

The influence of gestational hypertension on cord blood adiponectin levels: a case-controlled study
por: Justyna Czubilińska-Łada, et al.
Publicado: (2021)